Shortened Timelines for Regulatory Review by ANMAT Make Argentina an Excellent Choice for Clinical Research
July 27, 2017
Author: Wanda Dobrzanski M.D, Head of Clinical Operations Latin America, Medpace
On April 26th, The Ministry of Health in Argentina (ANMAT) issued a new regulation that significantly reduces the timelines for the approval of clinical trials. In this post, I discuss the key changes and the advantages this offers Sponsors who are looking to conduct clinical trials in Latin America.
Read More